{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T09:36:10Z","timestamp":1768556170859,"version":"3.49.0"},"posted":{"date-parts":[[2022,10,7]]},"group-title":"Nephrology","reference-count":65,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2022,10,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Chronic kidney disease (CKD) is a major public health issue worldwide and is an important contributor to the overall non-communicable disease burden. Chronic kidney disease is usually asymptomatic, and insidiously and silently progresses to advanced stages in resource limited settings.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methodology<\/jats:title>\n                  <jats:p>A prospective longitudinal study was carried out on black patients with CKD attending the kidney outpatient clinic at Charlotte Maxeke Johannesburg Academic Hospital (CMJAH) in South Africa, between September 2019 to March 2022. Demographic and clinical data were extracted from the ongoing continuous clinic records, as well as measurements of vital signs and interviews at baseline and at follow up. Patients provided urine and blood samples for laboratory investigations as standard of care at study entry (0) and at 24 months, and were followed up prospectively for two (2) years. Data were descriptively and inferentially entered into REDcap and analysed using STATA version 17, and multivariable logistic regression analysis was used to identify predictors of CKD progression.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>\n                    A total of 312 patients were enrolled into the study, 297 (95.2%) patients completed the study, 10 (3.2%) patients were lost to follow and 5 (1.6%) patients died during the study period. The prevalence of CKD progression was 49.5%, while that of CKD remission was 33% and CKD regression was 17.5%. For patients with CKD progression the median age at baseline was 58 (46 - 67) years, the median eGFR was 37 (32 -51) mL\/min\/1.73 m\n                    <jats:sup>2<\/jats:sup>\n                    , median urine protein creatinine ratio (uPCR) was 0.038 (0.016 -0.82) g\/mmol and the median haemoglobin (Hb) was 13.1 (11.7 \u2013 14.4) g\/dl; 95.2% had hypertension, 40.1% patients had diabetes mellitus and 39.5% had both hypertension and diabetes mellitus. Almost half (48.3%) of patients with CKD progression had severely increased proteinuria and 45.6% had anaemia. Variables associated with higher odds for CKD progression after multivariable logistic regression analysis were severely increased proteinuria (OR 32.3, 95 % CI 2.8 - 368.6, P = 0.005), moderately increased proteinuria (OR 23.3, 95% CI 2.6 - 230.1, P= 0.007), hypocalcaemia (OR 3.8, 95 % CI 1.0 - 14.8, P = 0.047), hyponatraemia (OR 4.5, 95% CI 0.8 - 23.6, P= 0.042), anaemia (OR 2.1, 95% CI 1.0 - 4.3, P= 0.048), diabetes mellitus (OR 1.8, 95 % CI 0.9 - 3.6, P = 0.047), elevated HbA1c (OR 1.8, 95 % CI 1.2 - 2.8, P = 0.007) and current smoking (OR 2.8, 95 % CI 0.9 - 8.6, P = 0.049).\n                  <\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusion<\/jats:title>\n                  <jats:p>Our study identified a higher prevalence of progression of CKD in a prospective longitudinal study of black patients with CKD. Progression of CKD was associated with proteinuria, diabetes mellitus, elevated HbA1c, anaemia, hypocalcaemia, hyponatraemia and current smoking. This is a call for nephrologists and clinicians to be vigilant in identifying CKD patients at risk of CKD progression at early stages as this would allow risk stratification to improve kidney disease outcomes.<\/jats:p>\n                <\/jats:sec>","DOI":"10.1101\/2022.10.06.22280771","type":"posted-content","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T12:02:26Z","timestamp":1665144146000},"source":"Crossref","is-referenced-by-count":0,"title":["Progression of chronic kidney disease among black patients attending a tertiary hospital in Johannesburg, South Africa"],"prefix":"10.64898","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5349-7717","authenticated-orcid":false,"given":"Alfred","family":"Meremo","sequence":"first","affiliation":[]},{"given":"Graham","family":"Paget","sequence":"additional","affiliation":[]},{"given":"Raquel","family":"Duarte","sequence":"additional","affiliation":[]},{"given":"Deogratius","family":"Bintabara","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7058-9725","authenticated-orcid":false,"given":"Saraladevi","family":"Naicker","sequence":"additional","affiliation":[]}],"member":"54368","reference":[{"issue":"10225","key":"2022100923550409000_2022.10.06.22280771v1.1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","year":"2020","journal-title":"The Lancet"},{"issue":"4","key":"2022100923550409000_2022.10.06.22280771v1.2","doi-asserted-by":"crossref","first-page":"e1003954","DOI":"10.1371\/journal.pmed.1003954","article-title":"Symptom burden and health-related quality of life in chronic kidney disease: A global systematic review and meta-analysis","volume":"19","year":"2022","journal-title":"PLoS medicine"},{"issue":"1","key":"2022100923550409000_2022.10.06.22280771v1.3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12882-021-02597-3","article-title":"Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990\u20132019: results from the global burden of disease study 2019","volume":"23","year":"2022","journal-title":"BMC Nephrology"},{"key":"2022100923550409000_2022.10.06.22280771v1.4","doi-asserted-by":"publisher","DOI":"10.1007\/978-981-13-8871-2_1"},{"issue":"2","key":"2022100923550409000_2022.10.06.22280771v1.5","doi-asserted-by":"crossref","first-page":"100403","DOI":"10.1016\/j.xkme.2021.11.001","article-title":"Obesity and CKD in Sub-Saharan Africa: A Narrative Review","volume":"4","year":"2022","journal-title":"Kidney Medicine"},{"issue":"5 Suppl 1","key":"2022100923550409000_2022.10.06.22280771v1.6","first-page":"S3","article-title":"Kidney Disease Among African Americans: A Population Perspective","volume":"72","year":"2018","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"issue":"6","key":"2022100923550409000_2022.10.06.22280771v1.7","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1053\/j.ajkd.2019.06.006","article-title":"Genetics and ESKD Disparities in African Americans","volume":"74","year":"2019","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"key":"2022100923550409000_2022.10.06.22280771v1.8","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2017-020145"},{"key":"2022100923550409000_2022.10.06.22280771v1.9","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193384"},{"issue":"1","key":"2022100923550409000_2022.10.06.22280771v1.10","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12882-018-0930-5","article-title":"Burden of chronic kidney disease on the African continent: a systematic review and meta-analysis","volume":"19","year":"2018","journal-title":"BMC nephrology"},{"key":"2022100923550409000_2022.10.06.22280771v1.11","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2016-015069"},{"issue":"2","key":"2022100923550409000_2022.10.06.22280771v1.12","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1159\/000514550","article-title":"Global Epidemiology of End-Stage Kidney Disease and Disparities in Kidney Replacement Therapy","volume":"52","year":"2021","journal-title":"American Journal of Nephrology"},{"issue":"2","key":"2022100923550409000_2022.10.06.22280771v1.13","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.kisu.2017.07.006","article-title":"Closing the gap between evidence and practice in chronic kidney disease","volume":"7","year":"2017","journal-title":"Kidney International Supplements"},{"issue":"3","key":"2022100923550409000_2022.10.06.22280771v1.14","first-page":"363","article-title":"Prevalence of chronic kidney disease and association with cardiovascular risk factors among teachers in Cape Town, South Africa","volume":"10","year":"2017","journal-title":"Clinical Kidney Journal"},{"issue":"5","key":"2022100923550409000_2022.10.06.22280771v1.15","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41581-019-0248-y","article-title":"Targeting the progression of chronic kidney disease","volume":"16","year":"2020","journal-title":"Nature reviews Nephrology"},{"key":"2022100923550409000_2022.10.06.22280771v1.16","doi-asserted-by":"crossref","unstructured":"Cortinovis M , Perico N , Ruggenenti P , Remuzzi A , Remuzzi G. Glomerular hyperfiltration. Nature reviews Nephrology. 2022.","DOI":"10.1038\/s41581-022-00559-y"},{"issue":"1","key":"2022100923550409000_2022.10.06.22280771v1.17","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1159\/000445844","article-title":"Progression, Remission and Regression of Chronic Renal Diseases","volume":"134","year":"2016","journal-title":"Nephron"},{"issue":"6","key":"2022100923550409000_2022.10.06.22280771v1.18","doi-asserted-by":"crossref","first-page":"e2112828","DOI":"10.1001\/jamanetworkopen.2021.12828","article-title":"Progression and Regression of Chronic Kidney Disease by Age Among Adults in a Population-Based Cohort in Alberta, Canada","volume":"4","year":"2021","journal-title":"JAMA network open"},{"issue":"6","key":"2022100923550409000_2022.10.06.22280771v1.19","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.kint.2018.01.008","article-title":"Different rates of progression and mortality in patients with chronic kidney disease at outpatient nephrology clinics across Europe","volume":"93","year":"2018","journal-title":"Kidney international"},{"key":"2022100923550409000_2022.10.06.22280771v1.20","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1159\/000488123","article-title":"Improving Global Kidney Health: International Society of Nephrology Initiatives and the Global Kidney Health Atlas","volume":"72","year":"2018","journal-title":"Annals of Nutrition and Metabolism"},{"issue":"7","key":"2022100923550409000_2022.10.06.22280771v1.21","first-page":"e9499","article-title":"Survival of the Fittest: Addressing the Disparities in the Burden of Chronic Kidney Disease","volume":"12","year":"2020","journal-title":"Cureus"},{"issue":"9","key":"2022100923550409000_2022.10.06.22280771v1.22","doi-asserted-by":"crossref","first-page":"e2127014","DOI":"10.1001\/jamanetworkopen.2021.27014","article-title":"Trends in Chronic Kidney Disease Care in the US by Race and Ethnicity, 2012-2019","volume":"4","year":"2021","journal-title":"JAMA network open"},{"key":"2022100923550409000_2022.10.06.22280771v1.23","unstructured":"Research NS . Health Survey for England 2016: adult health trends. Health and Social Care Information Centre London; 2017."},{"issue":"6","key":"2022100923550409000_2022.10.06.22280771v1.24","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.kint.2021.03.020","article-title":"Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference","volume":"99","year":"2021","journal-title":"Kidney international"},{"key":"2022100923550409000_2022.10.06.22280771v1.25","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.12791019"},{"key":"2022100923550409000_2022.10.06.22280771v1.26","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.6634"},{"issue":"1","key":"2022100923550409000_2022.10.06.22280771v1.27","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12882-018-0942-1","article-title":"Contemporary rates and predictors of fast progression of chronic kidney disease in adults with and without diabetes mellitus","volume":"19","year":"2018","journal-title":"BMC nephrology"},{"issue":"1","key":"2022100923550409000_2022.10.06.22280771v1.28","doi-asserted-by":"crossref","first-page":"15940","DOI":"10.1038\/s41598-018-34386-8","article-title":"Novel Urinary Biomarkers For Improved Prediction Of Progressive Egfr Loss In Early Chronic Kidney Disease Stages And In High Risk Individuals Without Chronic Kidney Disease","volume":"8","year":"2018","journal-title":"Scientific reports"},{"key":"2022100923550409000_2022.10.06.22280771v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208"},{"key":"2022100923550409000_2022.10.06.22280771v1.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2008.08.010"},{"issue":"717","key":"2022100923550409000_2022.10.06.22280771v1.31","doi-asserted-by":"crossref","first-page":"e261","DOI":"10.3399\/BJGP.2021.0477","article-title":"Change in glomerular filtration rate over time in the Oxford Renal Cohort Study: observational study","volume":"72","year":"2022","journal-title":"The British journal of general practice : the journal of the Royal College of General Practitioners"},{"issue":"1","key":"2022100923550409000_2022.10.06.22280771v1.32","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1186\/s12882-020-01852-3","article-title":"Ethnic minority disparities in progression and mortality of pre-dialysis chronic kidney disease: a systematic scoping review","volume":"21","year":"2020","journal-title":"BMC Nephrology"},{"issue":"12","key":"2022100923550409000_2022.10.06.22280771v1.33","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1159\/000519758","article-title":"Disparities in Chronic Kidney Disease Progression by Medicare Advantage Enrollees","volume":"52","year":"2021","journal-title":"American journal of nephrology"},{"issue":"2","key":"2022100923550409000_2022.10.06.22280771v1.34","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/MNH.0000000000000688","article-title":"Disparities in chronic kidney disease-the state of the evidence","volume":"30","year":"2021","journal-title":"Current opinion in nephrology and hypertension"},{"issue":"1","key":"2022100923550409000_2022.10.06.22280771v1.35","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12882-019-1502-z","article-title":"Racial disparities in end-stage renal disease in a high-risk population: the Southern Community Cohort Study","volume":"20","year":"2019","journal-title":"BMC nephrology"},{"issue":"9","key":"2022100923550409000_2022.10.06.22280771v1.36","doi-asserted-by":"crossref","first-page":"e1002128","DOI":"10.1371\/journal.pmed.1002128","article-title":"Chronic Kidney Disease in Primary Care: Outcomes after Five Years in a Prospective Cohort Study","volume":"13","year":"2016","journal-title":"PLoS medicine"},{"issue":"1","key":"2022100923550409000_2022.10.06.22280771v1.37","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1186\/s12882-020-01982-8","article-title":"Predictive factors of rapid linear renal progression and mortality in patients with chronic kidney disease","volume":"21","year":"2020","journal-title":"BMC Nephrology"},{"key":"2022100923550409000_2022.10.06.22280771v1.38","first-page":"8866446","article-title":"Chronic Kidney Disease Progression and Transition Probabilities in a Large Preventive Cohort in Colombia","volume":"2021","year":"2021","journal-title":"International journal of nephrology"},{"issue":"2","key":"2022100923550409000_2022.10.06.22280771v1.39","doi-asserted-by":"crossref","first-page":"e0246509","DOI":"10.1371\/journal.pone.0246509","article-title":"Prevalence and associated factors of impaired renal function and albuminuria among adult patients admitted to a hospital in Northeast Ethiopia","volume":"16","year":"2021","journal-title":"PloS one"},{"issue":"2","key":"2022100923550409000_2022.10.06.22280771v1.40","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1053\/j.ajkd.2020.12.013","article-title":"Association of Blood Pressure With the Progression of CKD: Findings From KNOW-CKD Study","volume":"78","year":"2021","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"issue":"2","key":"2022100923550409000_2022.10.06.22280771v1.41","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1053\/j.ajkd.2020.01.013","article-title":"Associations of Systolic Blood Pressure With Incident CKD G3-G5: A Cohort Study of South Korean Adults","volume":"76","year":"2020","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"issue":"1","key":"2022100923550409000_2022.10.06.22280771v1.42","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/ntr\/ntaa071","article-title":"Smoking, Smoking Cessation, and Progression of Chronic Kidney Disease: Results From KNOW-CKD Study","volume":"23","year":"2021","journal-title":"Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco"},{"key":"2022100923550409000_2022.10.06.22280771v1.43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1159\/000517749","article-title":"Smoking and Kidney Disease: Risk Factors, Challenges, and Preventive Strategies","volume":"199","year":"2021","journal-title":"Contributions to nephrology"},{"issue":"3","key":"2022100923550409000_2022.10.06.22280771v1.44","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.ajkd.2018.02.362","article-title":"Obesity, Metabolic Abnormality, and Progression of CKD","volume":"72","year":"2018","journal-title":"American journal of kidney diseases : the official journal of the National Kidney Foundation"},{"key":"2022100923550409000_2022.10.06.22280771v1.45","doi-asserted-by":"crossref","unstructured":"Strazzella A , Ossoli A , Calabresi L. High-Density Lipoproteins and the Kidney. Cells. 2021;10(4).","DOI":"10.3390\/cells10040764"},{"issue":"8","key":"2022100923550409000_2022.10.06.22280771v1.46","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1111\/dom.14401","article-title":"Prevalence and progression of chronic kidney disease among patients with type 2 diabetes: Insights from the DISCOVER study","volume":"23","year":"2021","journal-title":"Diabetes, obesity & metabolism"},{"issue":"2","key":"2022100923550409000_2022.10.06.22280771v1.47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2169\/internalmedicine.3242-19","article-title":"Effects of HbA1c on the Development and Progression of Chronic Kidney Disease in Elderly and Middle-Aged Japanese: Iki Epidemiological Study of Atherosclerosis and Chronic Kidney Disease (ISSA-CKD)","volume":"59","year":"2020","journal-title":"Internal medicine (Tokyo, Japan)"},{"key":"2022100923550409000_2022.10.06.22280771v1.48","doi-asserted-by":"crossref","first-page":"854300","DOI":"10.3389\/fmed.2022.854300","article-title":"Association Between Urinary Protein-to-Creatinine Ratio and Chronic Kidney Disease Progression: A Secondary Analysis of a Prospective Cohort Study","volume":"9","year":"2022","journal-title":"Frontiers in medicine"},{"key":"2022100923550409000_2022.10.06.22280771v1.49","doi-asserted-by":"publisher","DOI":"10.2337\/dc19-1438"},{"issue":"11","key":"2022100923550409000_2022.10.06.22280771v1.50","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.mayocp.2019.09.014","article-title":"How Do We Navigate the Complexities Surrounding the Use of Angiotensin-Converting Enzyme Inhibitors\/Angiotensin Receptor Blockers in Chronic Kidney Disease?","volume":"94","year":"2019","journal-title":"Mayo Clinic Proceedings"},{"key":"2022100923550409000_2022.10.06.22280771v1.51","unstructured":"Leon SJ , Whitlock R , Rigatto C , Komenda P , Bohm C , Sucha E , et al. Hyperkalemia-Related Discontinuation of Renin-Angiotensin-Aldosterone System Inhibitors and Clinical Outcomes in CKD: A Population-Based Cohort Study. American Journal of Kidney Diseases."},{"key":"2022100923550409000_2022.10.06.22280771v1.52","unstructured":"Shaikh H , Aeddula NR . Anemia Of Chronic Renal Disease. StatPearls. Treasure Island (FL): StatPearls Publishing Copyright \u00a9 2022, StatPearls Publishing LLC.; 2022."},{"issue":"2","key":"2022100923550409000_2022.10.06.22280771v1.53","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/ckj\/sfab195","article-title":"Contemporary outcomes of anemia in US patients with chronic kidney disease","volume":"15","year":"2022","journal-title":"Clinical kidney journal"},{"key":"2022100923550409000_2022.10.06.22280771v1.54","doi-asserted-by":"crossref","first-page":"1759720x211016661","DOI":"10.1177\/1759720X211016661","article-title":"Hyperuricemia, urate-lowering therapy, and kidney outcomes: a systematic review and meta-analysis","volume":"13","year":"2021","journal-title":"Therapeutic advances in musculoskeletal disease"},{"issue":"4","key":"2022100923550409000_2022.10.06.22280771v1.55","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1590\/2175-8239-jbn-2020-u002","article-title":"Hyperuricemia and chronic kidney disease: to treat or not to treat","volume":"43","year":"2021","journal-title":"Jornal brasileiro de nefrologia : \u2018orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia"},{"key":"2022100923550409000_2022.10.06.22280771v1.56","doi-asserted-by":"crossref","unstructured":"Chang YP , Liao CM , Wang LH , Hu HH , Lin CM . Static and Dynamic Prediction of Chronic Renal Disease Progression Using Longitudinal Clinical Data from Taiwan\u2019s National Prevention Programs. Journal of clinical medicine. 2021;10(14).","DOI":"10.3390\/jcm10143085"},{"issue":"7","key":"2022100923550409000_2022.10.06.22280771v1.57","first-page":"e16388","article-title":"Secondary Hyperparathyroidism in Chronic Kidney Disease: Pathophysiology and Management","volume":"13","year":"2021","journal-title":"Cureus"},{"issue":"1","key":"2022100923550409000_2022.10.06.22280771v1.58","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40620-021-00969-4","article-title":"Association between serum phosphorus and mortality in NHANES 2003-2006: the effect of gender and renal function","volume":"35","year":"2022","journal-title":"Journal of nephrology"},{"key":"2022100923550409000_2022.10.06.22280771v1.59","doi-asserted-by":"crossref","first-page":"654250","DOI":"10.3389\/fmed.2021.654250","article-title":"Optimizing Diet to Slow CKD Progression","volume":"8","year":"2021","journal-title":"Frontiers in medicine"},{"key":"2022100923550409000_2022.10.06.22280771v1.60","doi-asserted-by":"crossref","first-page":"769287","DOI":"10.3389\/fmed.2021.769287","article-title":"Dysnatremias in Chronic Kidney Disease: Pathophysiology, Manifestations, and Treatment","volume":"8","year":"2021","journal-title":"Frontiers in medicine"},{"issue":"2","key":"2022100923550409000_2022.10.06.22280771v1.61","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1093\/ndt\/gfab203","article-title":"Association of pre-ESKD hyponatremia with post-ESKD outcomes among incident ESKD patients","volume":"37","year":"2022","journal-title":"Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association"},{"key":"2022100923550409000_2022.10.06.22280771v1.62","first-page":"653634","article-title":"Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options","volume":"8","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"2022100923550409000_2022.10.06.22280771v1.63","doi-asserted-by":"crossref","first-page":"s31","DOI":"10.1590\/1806-9282.66.s1.31","article-title":"Hyperkalemia in chronic kidney disease","volume":"66","year":"2020","journal-title":"Revista da Associacao Medica Brasileira (1992)"},{"issue":"6","key":"2022100923550409000_2022.10.06.22280771v1.64","first-page":"452","article-title":"Metabolic Acidosis in Patients with CKD: Epidemiology, Pathogenesis, and Treatment","volume":"7","year":"2021","journal-title":"Kidney diseases (Basel, Switzerland)"},{"issue":"1","key":"2022100923550409000_2022.10.06.22280771v1.65","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s12882-021-02385-z","article-title":"Metabolic acidosis is associated with increased risk of adverse kidney outcomes and mortality in patients with non-dialysis dependent chronic kidney disease: an observational cohort study","volume":"22","year":"2021","journal-title":"BMC nephrology"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2022.10.06.22280771","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T14:51:50Z","timestamp":1768488710000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.1101\/2022.10.06.22280771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,7]]},"references-count":65,"URL":"https:\/\/doi.org\/10.1101\/2022.10.06.22280771","relation":{"is-preprint-of":[{"id-type":"doi","id":"10.1371\/journal.pone.0276356","asserted-by":"subject"}]},"subject":[],"published":{"date-parts":[[2022,10,7]]},"subtype":"preprint"}}